Introduction of CHA Medical Group

Cha Medical Group started as a CHA OBGYN Clinic in 1960, located in Cho-dong, Jung-gu, Seoul. Since then, it has continued to grow and become one of the major Korean medical groups that has 8 hospitals in Korea including general hospitals such as CHA Gangnam Medical Center, CHA Bundang Medical Center, and CHA Gumi Medical Center. Also, in 1999, Cha Medical Group established CHA-Columbia Fertility Center at Columbia University and has been writing a new history of domestic medicine’s global outreach since it became the first in Korea to export domestic medicine. In 2002, it acquired CHA-Hollywood Presbyterian Medical Center (HMPC) in the U.S. and became the largest shareholder of the CFC (City Fertility Center), a fertility center in Australia in 2018. Cha Medical Group now has a global medical network with a total of 2400 global employees, around 50 hospitals and clinics in 7 countries, and 700 medical staff. Behind this achievement is the infertility medicine of Cha Medical Group. In 1986, Cha Medical Group became the first in Korea to succeed the IVF procedure and in the same year, it became the first in the world to accomplish the gamete intra fallopian transfer (GIFT). In 1998, it became the first to develop the vitrified egg freezing method and standard technology for egg freezing, leading the global fertile reproductive medicine in clinical and technical fields. Cha Medical Group has been striving to develop cures for intractable diseases through stem cell research based on its fertility reproductive technology and have had some success. In 2014, it attracted the attention of both domestic and foreign academia by publishing “Human somatic cell nuclear transfer using adult skin cells” in the 'Cell Stem Cell', a leading scientific journal in the stem cell field, and. In 2015, Cha Medical Group also dramatically improved the success rate of somatic-cell nuclear transfer, increasing the possibility of the world's first customized stem cell therapy. Cha Medical Group is preparing to enter the global market by developing cures for intractable diseases and new drugs, and become a top-notch global medical institution. To this end, it will actively utilize its industry-academia systems that include its domestic and overseas medical networks, companies such as CHA Biotech and CMG Pharmaceuticals, CHA University, and its research institutes in order to become a new medical paradigm for the era of the 4th Industrial Revolution.

English
닫기 버튼

History of CHA Medical Group

The work of studying the mysteries of life, human life more mysterious than the universe, to discover ground-breaking treatments in maintaining a healthy life has been the mission upheld by CHA Group for a half-century, and the faithful path of a medical group serving humankind.
Now we strive toward a new, greater ideal of becoming a world-class biomedical group that brings happiness into the life of humanity

World’s first successful completion ofthe adult somatic stem cell cloningby CHA Group becomes the history of life science itself.
Our endless challenge toward the achievement of well-aging for mankind will never cease.

CHA Group, which began its new challenge toward being a world-class biomedical group, will change the global medical paradigm and open up a new era of life science.
CHA Bio Complex, a future of bio research experience spanning a half-century with medical and scientific vision and results.
With the hospital as its platform, CHA Bio Complex will research, communicate, and fuse countless methods that can cure disease through synergetic collaboration with universities, research institutes, and biomedical companies to take its place in the world as a stem-cell research hub.
CHA Group is building a network of hospitals affiliated with CHA University Medical Schools throughout major cities in South Korea. The futuristic life center, “Chaum”, is opening a new chapter in “Total Healthcare” by merging Eastern and Western medicine that comprehensively cares for the health of body and mind.
Starting with Gangnam CHA Medical Center at the helm, the history and present hallmark of women’s medicine in Korea, Bundang CHA Medical Center, a research centered general hospital gaining fame, and the hospitals providing the most cutting edge medical services to local communities, Daegu CHA Medical Center and Gumi CHA Medical Center, make up the key network stations in South Korea.
Overseas, the network extends toHPMC is the biggest privately owned hospital in LA, CA and to Japan with Tokyo cell clinicin Toyko, with goals to push forward into China, Russia, and other regions.

CHA University, a university unique in the world featuring three core connected institutions of research, hospitals, and business.
From its inception, CHA University has provided generous support through programs such as full scholarships to its entire medical faculty in order to cultivate skilled medical professionals.
CHA Group, currently operate 10 biomedical related companies including 3 companies that went publictaking on the endless challenge of seeking out innovative ways for humankind to manage health and youth.
The work of developing cures and solutions for incurable diseases through stem cell research, bringing new hope for humankind through achievements in genomic research and infertility, seeking out groundbreaking methods able to manage health and youth, and to bring new hope to humanity through the development of biomedical and biotech products.
This is why CHA Group operates companies related to biotechnology and it is this mindset that compels us to make the spirit of having “respect for life” a reality.

Epilogue

Birth, which by itself illustrates the mystery of human life…
Throughout the ever growing life of humanity, know that CHA Group’s biotechnology for aging well is with you every step of the way.

This is the direction of our future and the reason that the world will regard CHA Group as a global medical leader.

A flagship of biotechnology. CHA Group!

Korean
닫기 버튼

차병원그룹의 역사

우주보다 신비한 인간의 생명, 그 생명의 신비를 연구하여 건강한 생명을 유지하기 위한 획기적인 치료법을 찾아내는 일,반세기 차병원그룹을 지켜온 사명이었고, 인류를 위해 봉사하는 의료그룹의 참된 길이었습니다.이제 우리는 더 새롭고 ,더 큰 가치를 향해 도전하여 인류의 라이프 타임에 행복을 선사하는 세계적인 바이오 메디컬그룹을 향해 나아갈 것입니다.

세계 최초 성인의 체세포를 이용한 체세포 복제 줄기세포주 확립 성공 , 그 자체로 생명의학의 역사인 차 병원 그룹의 역사, 인류의 웰 에이징을 향한 우리의 끝없는 도전은 여기서 멈추지 않을 것입니다.세계적인 바이오 메디컬 그룹을 향해 새로운 도전을 시작한 차병원그룹 ,반세기 바이오 연구의 노하우와 의학적, 과학적 성과 및 비전이 응집된 차 바이오 콤플렉스의 오픈과 함께 세계 의학계의 패러다임을 바꾸고 생명의학의 새시대를 열어갈 것입니다.

차 바이오 콤플렉스는 병원을 플랫폼으로 대학, 연구소, 바이오 메디컬 기업의 화학적 결합을 통해, 질병을 해결할 수 있는수많은 방법을 연구하고 소통하며 융합하여세계 줄기세포 연구의 허브로 자리매김할 것입니다.

차 병원그룹은 국내 주요도시에 차의과학대학교 부속병원의네트워크를 구축하고 있습니다미래형 라이프센터인 <차움>은동양과 서양의학의 융합을 통해 몸과 마음의 건강을 통합 관리하는 <토털 헬스케어>의 새로운 장을 열어가고 있습니다

한국 여성의학의 역사이자 현재인강남 차병원을 위시하여,연구중심의 병원으로 큰 명성을 얻고 있는 최고의 종합병원으로서분당 차병원, 지역주민들을 위해 첨단 의료서비스를 펼치고 있는대구 차병원과 구미차병원 등이 있습니다.

해외 네트워크로는미국 LA에 위치한 할리우드장로병원과일본 동경에 위치한 다께시바센터 등이 있으며,현재 중국, 러시아 등지에 차병원 설립을 추진하고 있습니다.

연구소,병원,기업의 3가지 핵심연계기관을 보유한 세계유일의 대학인 차의과학대학, 개교 이래 의학부 전원에게전액 장학금을 지급하는 등 역량있는 의료진을 양성하기 위해아낌없는 지원을 하고 있습니다.

인류가 건강과 젊음을 관리할 수 획기적인 방법을 찾기 위해끝없이 도전하는 차병원그룹, 줄기세포를 연구하여난치성 질환을해결하는 치료제를 개발하고, 유전체와 불임생식연구의 산물로써인류에게 새로운 희망을 제공하고 ,건강과 젊음을 관리를 할 수 있는획기적인 방법을 찾아내는 일,바이오 관련 제품을 개발하여 인류에게 희망을 주는 일 ,이것이 바로 차병원그룹이 바이오 관련 기업을 경영하는 이유이며 생명존중의 의지를 실천해 나가는 우리의 정신입니다.

Epil

탄생, 그 자체로 신비한 인류의 생명, 삶이 성장하는 인류의 전 생애 속에차병원그룹의 웰 에이징을 위한 바이오 기술이늘 함께 할 것입니다.

이것이 바로 우리가 그려갈 미래이며,세계가 차병원그룹을 글로벌 메디컬 리더라 부르는 이유가 될 것입니다.

바이오 입국. 차병원그룹!

scroll to top button